TLR3 Antibody (Highly Specific, Highly Pure)

Product Description

TLR3 Antibody
Catalog number: B2010437
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 ug
Molecular Weight or Concentration: 150 kDa
Supplied as: Solution
Appearance: Clear Solution
Applications: Highly pure polyclonal antibody specific to human TRL3.
Storage: -20C
Keywords: toll-like receptors 3, toll-like receptor 3
Grade: Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Suresh MV, Dolgachev VA, Zhang B, Balijepalli S, Swamy S, Mooliyil J,
Kralovich G, Thomas B, Machado-Aranda D, Karmakar M, Lalwani S, Subramanian A,
Anantharam A, Moore BB, Raghavendran K. TLR3 absence confers increased survival
with improved macrophage activity against pneumonia. JCI Insight. 2019 Dec
5;4(23):e131195.

2: Sato R, Kato A, Chimura T, Saitoh SI, Shibata T, Murakami Y, Fukui R, Liu K,
Zhang Y, Arii J, Sun-Wada GH, Wada Y, Ikenoue T, Barber GN, Manabe T, Kawaguchi
Y, Miyake K. Combating herpesvirus encephalitis by potentiating a TLR3-mTORC2
axis. Nat Immunol. 2018 Oct;19(10):1071-1082.

3: Karikó K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by
Toll-like receptors: the impact of nucleoside modification and the evolutionary
origin of RNA. Immunity. 2005 Aug;23(2):165-75.

4: Patel S, Sinigaglia A, Barzon L, Fassan M, Sparber F, LeibundGut-Landmann S,
Ackermann M. Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV. Viruses.
2019 Jul 3;11(7):603.

5: Liu Y, Yin H, Zhao M, Lu Q. TLR2 and TLR4 in autoimmune diseases: a
comprehensive review. Clin Rev Allergy Immunol. 2014 Oct;47(2):136-47.

6: Schau I, Michen S, Hagstotz A, Janke A, Schackert G, Appelhans D, Temme A.
Targeted delivery of TLR3 agonist to tumor cells with single chain antibody
fragment-conjugated nanoparticles induces type I-interferon response and
apoptosis. Sci Rep. 2019 Mar 1;9(1):3299.

7: Chaikeawkaew D, Everts V, Pavasant P. TLR3 activation modulates
immunomodulatory properties of human periodontal ligament cells. J Periodontol.
2020 Sep;91(9):1225-1236.

8: Sweere JM, Van Belleghem JD, Ishak H, Bach MS, Popescu M, Sunkari V, Kaber G,
Manasherob R, Suh GA, Cao X, de Vries CR, Lam DN, Marshall PL, Birukova M,
Katznelson E, Lazzareschi DV, Balaji S, Keswani SG, Hawn TR, Secor PR, Bollyky
PL. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial
infection. Science. 2019 Mar 29;363(6434):eaat9691.

9: Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N,
Perera-Lecoin M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau VM,
Choumet V, Briant L, Desprès P, Amara A, Yssel H, Missé D. Biology of Zika Virus
Infection in Human Skin Cells. J Virol. 2015 Sep;89(17):8880-96.
10: Flavell DJ, Holmes SE, Warnes SL, Flavell SU. The TLR3 Agonist Poly
Inosinic:Cytidylic Acid Significantly Augments the Therapeutic Activity of an
Anti-CD7 Immunotoxin for Human T-cell Leukaemia. Biomedicines. 2019 Feb
16;7(1):13.

Products Related to TLR3 Antibody: Antibodies